MARK W. HOLLADAY,GANG LIU,MARTIN W. ROWBOTTOM,MICHAEL J. HADD,MICHAEL D. HOCKER,SHIMIN XU
申请号:
PT12780613
公开号:
PT2766359T
申请日:
2012.10.12
申请国别(地区):
PT
年份:
2016
代理人:
摘要:
Provided herein are heterocyclic compounds for treatment of CSF1R, FLT3, KIT, and/or PDGFR&bgr; kinase mediated diseases. Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and compositions.